H-56/CAF-09

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameH-56/CAF-09

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionCluster of differentiation 8 stimulantsT-cell surface antigen CD4 agonists

TargetsT-cell surface antigen CD4Cluster of differentiation 8

Therapy Area/IndicationsTuberculosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Pittsburgh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Pittsburgh

Active IndicationsN/A

Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A